en

PRODUCT DETAIL

Nintedanib Accord 150 mg mäkké kapsuly

Code 6169E
MA number EU/1/24/1803/010
Product Form: cps mol 60x1x150 mg (blis.Al/Al-jednotk.bal.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EX Other protein kinase inhibitors
L01EX09 Nintedanib
Shelf life: 36
Container: blister Al/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 19.04.2024
Validity: 19.04.2029
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 02.05.2024
eu-flag.png sk-flag.png